Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
VBI Vaccines (VBIV) Prices 26.8M Share Common Offering $1.40/Sh
-
VBI Vaccines Announces Pricing of $37.5 Million Public Offering
-
VBI Vaccines Announces Pricing of $37.5 Million Public Offering
-
VBI Vaccines (VBIV) Announces Proposed Common Share Offering
-
VBI Vaccines Announces Proposed Public Offering of Common Shares
-
VBI Vaccines Announces Proposed Public Offering of Common Shares
-
VBI Vaccines to Present at the Canaccord Genuity 38th Annual Growth Conference
-
VBI Vaccines to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Canaccord Genuity Starts VBI Vaccines (VBIV) at Buy
-
VBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares
-
VBI Vaccines Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Upsized Registered Direct Offering for Aggregate Proceeds of $71.9 Million
-
VBI Vaccines (VBIV) Prices Common Stock Offerings at $3.05/Share
-
VBI Vaccines Prices Concurrent Public Offering and Registered Direct Offering for Aggregate Proceeds of $63.5 Million
-
VBI Vaccines (VBIV) Commences Concurrent Public Offering and Registered Direct Offering of Common Shares
-
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares

